News

Exploring Bonduelle's Monthly Share and Voting Rights Status

Exploring Bonduelle's Monthly Share and Voting Rights Status

Understanding Bonduelle’s Monthly Share and Voting Rights Update

Bonduelle, a prominent name in the agri-food sector, is renowned for its commitment to quality and sustainable practices. This article provides a detailed overview of the company's monthly insights regarding shares and voting rights. Such transparency is crucial for investors and stakeholders who follow Paris:BON.

Company Overview and Capital Structure

Headquartered at 'La Woestyne,' Bonduelle is established as a French S.C.A. with a registered capital of €57,102,699.50. This foundation reflects its stable structure, which allows Bonduelle to operate effectively in the competitive marketplace. The company's registration can be found under number 447 250 044 in the Dunkerque Commercial and Companies Register.

Monthly Voting Rights Information

As part of its commitment to transparency, Bonduelle releases regular updates concerning the voting rights attached to its share capital. As per regulatory requirements, this monthly report is essential to keep stakeholders informed about the total number of shares and the associated voting rights.

Current Shareholder Insights

According to the latest update, the total number of shares in Bonduelle's capital stands at 32,630,114. These shares determine the company's share capital and play a crucial role in decision-making processes during shareholder meetings, ensuring that every invested stakeholder has a say in the future direction of the company.

Details on Voting Rights

Voting rights are an essential element for investors, allowing them to influence the management and operational decisions of the company. The latest report indicates a theoretical total of 52,507,209 voting rights, where actual voting rights total 51,961,493. The difference arises from shares without voting rights, which highlights the importance of understanding share classifications for effective investment strategies.

Importance of Transparency in Corporate Governance

Bonduelle’s commitment to providing clear and timely information regarding its share structure and voting rights reflects its dedication to corporate governance. Transparency in these practices nurtures trust among investors, enabling them to make informed decisions. As a stakeholder, you can actively participate in the company’s future by being aware of such updates.

Conclusion on Bonduelle’s Share and Voting Practices

In summary, Bonduelle remains vigilant in communicating essential information concerning its equity and voting rights. This approach not only aligns with regulatory requirements but also fortifies the relationship with its investors. With Paris:BON at the forefront, Bonduelle continues to pave the way for informed investment through transparency and engagement.

Frequently Asked Questions

What is Bonduelle's capital structure?

Bonduelle operates with a registered capital of €57,102,699.50, structured as a French S.C.A.

How many shares are there in Bonduelle's capital?

Recently, Bonduelle reported a total of 32,630,114 shares in its capital.

How do I understand Bonduelle’s voting rights?

Voting rights are crucial for influencing management decisions, with a theoretical right total of 52,507,209 and actual rights at 51,961,493.

Why does Bonduelle provide monthly updates?

Monthly updates ensure transparency and keep shareholders informed about significant changes in the company’s share structure.

What is the significance of shares without voting rights?

Shares without voting rights can affect the overall voting total, as they do not contribute to shareholder decision-making processes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 13

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 24

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Inbank Reports Impressive Growth in Financial Performance

Updated Category News Views 237

Inbank's Stellar Financial Performance in Recent Quarters Inbank has achieved significant milestones in its Q2 2025 financial results, showcasing dynamic growth and resilience in a fluctuating market. The bank reported a remarkable originated volume of 196 million euros, marking a 15% increase from the previous year. Although consolidated net profit saw a slight decline...

Continue Reading
Navient Elects Edward Bramson as Chair After Shareholder Meeting

Updated Category News Views 164

Navient's Annual Meeting Marks a New Chapter HERNDON, Va. - Recently, Navient (Nasdaq: NAVI) convened its Annual Meeting of Shareholders, setting the stage for significant leadership changes within the company. This year, shareholders engaged actively, voting to approve three pivotal proposals outlined by the board of directors. This included the election of seven new...

Continue Reading
Annexon Secures $75 Million in Public Stock Offering

Updated Category News Views 184

Overview of Annexon's Recent Public Offering Annexon, Inc. (NASDAQ: ANNX), a pioneering biopharmaceutical firm, recently announced the successful pricing of its public offering aimed at raising $75 million. This exciting event took place as the company continues to push forward with its mission to address neuroinflammation and related diseases, facilitating groundbreaking...

Continue Reading
Werner Enterprises Set for Key Investment Conferences This Year

Updated Category News Views 310

Werner Enterprises is Poised for Investment Conference Engagements Werner Enterprises, Inc. (Nasdaq: WERN), a well-known name in transportation and logistics, is preparing to participate in several significant investment conferences. These events present a fantastic opportunity for the company to share insights about its growth strategies and market position. Upcoming...

Continue Reading
Cunard Achieves Unprecedented Booking Milestones in 2024

Updated Category News Views 156

Record-Breaking Booking Success for Cunard Cunard has recently announced remarkable booking figures for the year 2024, driven by a stellar year and the eagerly awaited introduction of its ship, Queen Anne. This significant increase has resulted in an astonishing 73,000 more guest reservations from January to October compared to the same timeframe in the previous year,...

Continue Reading